title: Attention deficit hyperactivity disorder: part III.
authors.affiliation: Yale University School of Nursing, NewHaven, CT 06536-0740, USA. patricia.ryan-krause@yale.edu
authors.forename: Patricia
authors.initials: P
authors.lastname: Ryan-Krause
mesh_terms: D018759:Adrenergic Uptake Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D000069445:Atomoxetine Hydrochloride; D001289:Attention Deficit Disorder with Hyperactivity / Q000175:diagnosis* / Q000188:drug therapy / Q000628:therapy; D001521:Behavior Therapy; D000697:Central Nervous System Stimulants / Q000009:adverse effects / Q000627:therapeutic use*; D004522:Educational Status; D006801:Humans; D008603:Mental Health; D008774:Methylphenidate / Q000009:adverse effects / Q000627:therapeutic use*; D011437:Propylamines / Q000627:therapeutic use
chemical_list: D018759:Adrenergic Uptake Inhibitors; D000697:Central Nervous System Stimulants; D011437:Propylamines; D008774:Methylphenidate; D000069445:Atomoxetine Hydrochloride